UK officials bust illegal weight loss drug production facility — largest seizure of popular pens in the world
A recent raid in the UK has resulted in the largest seizure of unlicensed weight loss drugs globally. The Medicines and Healthcare products Regulatory Agency (MHRA) conducted the raid, confiscating thousands of knockoff pens from an illicit manufacturing facility in Northampton.
During the two-day search of the warehouse, enforcement agents discovered tens of thousands of empty weight loss pens, raw chemical ingredients, and over 2,000 unlicensed retatrutide and tirzepatide pens awaiting dispatch. Tirzepatide, known as Zepbound in the US, and retatrutide, a GLP-1 still in clinical development and banned in the UK, were among the seized products with a street value exceeding $300,000.
In addition to the drugs, sophisticated packaging and manufacturing equipment were found, along with approximately £20,000 in cash suspected to be linked to medicines trafficking.
Health and Social Care Secretary Wes Streeting praised the raid as a victory against criminals endangering lives by selling dangerous and illegal weight loss products for profit. He warned the public against purchasing weight loss medications from unregulated sources and supporting criminals who prioritize profit over safety and quality.
This marks the first discovery of an illicit production facility for weight loss drugs in the UK, highlighting the ongoing battle against illegal drug trafficking. The MHRA’s efforts in dismantling this operation demonstrate their commitment to ensuring the safety and well-being of consumers.
